Evidence map›Paper›PMID 42307052›Full record

ReviewBiotechnology journal2026

Base Editors for Engineering Industrial Microorganisms: Types, Applications, and Future Perspectives.

Xurui Li, Shimin Wu, Pingfang Tian

Abstract readReview
In one paragraph

Review in Biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xurui LiBeijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, P. R. China.
Shimin WuBeijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, P. R. China.
Pingfang TianBeijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, P. R. China.

Funding

National Natural Science Foundation of China 22278022
6 · The paper itself

Abstract

Base editing encompasses technologies that enable the direct conversion of one nucleotide base into another, typically by employing deaminases fused to programmable DNA- or RNA-binding scaffolds such as CRISPR-dCas9/nCas9. Deaminase-free editing strategies are also emerging as promising alternatives. Unlike conventional CRISPR-Cas9 systems that rely on DNA double-strand breaks (DSBs) and subsequent homology-directed repair or non-homologous end joining (NHEJ), base editors operate independently of these pathways, thus enabling continuous in vivo genome evolution and phenotypic diversification. While previous reviews have summarized base editing in plants and animals, the present review focuses specifically on base editors tailored for industrial microorganisms. We provide a comprehensive overview of deaminase-dependent and glycosylase-dependent base editors, emphasizing their applications in sculpting microbial genomes, redirecting metabolic flux, and enhancing stress tolerance. In addition, we summarize recent advances in in situ bacterial base editing, an emerging frontier for industrial strain improvement. Finally, we dissect the current limitations of these tools and propose actionable strategies to enhance editing performance and broaden their applicability. By integrating these perspectives, this review aims to guide future development and deployment of base editing technologies in both model and non-model industrial microorganisms, ultimately advancing their roles in biomanufacturing, biomonitoring, and beyond.

Indexed as

Gene EditingIndustrial MicrobiologyMetabolic EngineeringBacteriaCRISPR-Cas Systemsbase editingCRISPR‐dCas9deaminaseindustrial microorganismmetabolic engineering

Identifiers

PMID42307052
PMCPMC13383619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.